Prosecution Insights
Prosecution Insights
Technology area: Computing & Software
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Endra Life Sciences Inc. is currently engaged in patent prosecution within the Computing & Software technology area. The portfolio features 1 pending office action, which represents a focused effort to secure intellectual property in this sector. This matter is being handled by EHNE, CHARLES, the company's busiest examiner. Because EHNE, CHARLES is responsible for 1 pending office action, the company's immediate prosecution results are tied to the review of this single official.
The data indicates a highly concentrated administrative structure, with only 1 distinct examiner and 1 distinct art unit involved. This suggests that the company's current innovations are situated within a specific technical category of Computing & Software. For a practitioner, this concentration means that the entire pending portfolio is subject to the standards of a single art unit. The presence of 1 distinct examiner implies that the company has a singular point of interaction with the patent office for its current workload.
From a strategic perspective, the involvement of 1 distinct examiner allows for a direct and consistent communication channel. However, it also means that the company's success with its 1 pending office action is entirely dependent on the preferences of EHNE, CHARLES. The alignment of the portfolio within 1 distinct art unit simplifies the management of technical arguments but limits exposure to different examination perspectives. Practitioners should prioritize understanding the specific requirements of this 1 distinct examiner to advance the company's interests.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| EHNE, CHARLES | 1 | 92.1% | +8.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18695870 | Methods And Systems For Exchange Of Equipment Performance Data | EHNE, CHARLES | 55d |
| Art Unit | Apps |
|---|---|
| 2113 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18695870 | Methods And Systems For Exchange Of Equipment Performance Data | EHNE, CHARLES | 2113 | §101§102Other | Non-Final OA | 55d | Pending | Mar 27, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialEndra Life Sciences Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Charles Ehne has the most, with 1 of Endra Life Sciences Inc.'s pending office actions.
Mostly Computing & Software (USPTO Tech Center 2100), based on where its pending office actions are examined.